SAMONE WULF: Open Payments
NPI 1962035576 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,041 in 80 payments from 16 companies in 2025. Trend: 2023 $430 · 2024 $506 · 2025 $1,041
Food & beverage: $1,041
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 29 | $339 |
| ABBVIE INC. | 16 | $206 |
| ANI Pharmaceuticals, Inc. | 14 | $139 |
| UCB, Inc. | 3 | $65 |
| GlaxoSmithKline, LLC. | 4 | $61 |
| PFIZER INC. | 2 | $49 |
| Mallinckrodt Hospital Products Inc. | 2 | $29 |
| AstraZeneca Pharmaceuticals LP | 2 | $29 |
| Genentech USA, Inc. | 1 | $25 |
| Janssen Biotech, Inc. | 1 | $19 |
Products named: RINVOQ, PURIFIED CORTROPHIN GEL, OTEZLA, EVENITY, TAVNEOS, Bimzelx, BENLYSTA, XELJANZ.
Industry payments across NE — which companies pay providers there.
